Timothy Bisson

Tim Bisson is an experienced executive in market access and strategic planning within the biopharmaceutical industry. Currently serving as Vice President of Market Access and Executive Director at BridgeBio since November 2018, Tim has previously held senior roles at QED Therapeutics and Incyte, where responsibilities included managing National Accounts and patient services. With a strong foundation at Takeda Oncology, Tim led teams to enhance reimbursement access for various oncology products and developed strategic plans for market positioning. Earlier career experiences include positions at Aventis Pharmaceuticals, Roche Pharmaceuticals, and Bristol-Myers Squibb. Tim holds an Executive Education in High Impact Leadership from Columbia Business School, a Mini-MBA in BioPharma Innovation from Rutgers University, and a B.S. in Exercise Physiology from Springfield College.